Is bariatric surgery an effective treatment for type II diabetic kidney disease?

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 3, 2016, Pages 528-535

  Friedman, Allon N ^a   Wolfe, Bruce ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; BARIATRIC SURGERY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIABETIC NEPHROPATHY; DISEASE COURSE; DYSGLYCEMIA; FOLLOW UP; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH CARE SURVEY; HUMAN; KIDNEY TRANSPLANTATION; KNOWLEDGE; META ANALYSIS (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION; ADVERSE EFFECTS; COST BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ECONOMICS; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; TREATMENT OUTCOME;

BARIATRIC SURGERY; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HEALTH CARE COSTS; HUMANS; OBESITY; REMISSION INDUCTION; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84960158149     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07670715     Document Type: Article

References (59)

1. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J: Temporal trends in the prevalence of diabetic kidney disease in S the United States. JAMA 305: 2532-2539, 2011
2. Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D, Mogensen CE: Diabetic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes. Kidney Int 87: 20-30, 2015
3. Friedman A: Implications and management of obesity in kidney disease. In: Nutrition in Kidney Disesae, edited by Byham-Gray L, Burrows J, Chertow G, New York, Springer, 2014
4. Atkins RC, Zimmet P: Diabetic kidney disease: Act now or pay later. Kidney Int 77: 375-377, 2010
5. US Renal Data System: USRDS 2014 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014
6. Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH: Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 24: 302-308, 2013
7. Foley RN, Collins AJ: The growing economic burden of diabetic kidney disease. Curr Diab Rep 9: 460-465, 2009
8. de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, ChristSchmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators: Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med 369: 2492-2503, 2013
9. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 36[Suppl 1]: S67-S74, 2013
10. Centers for Disease Control: Maps of Trends in Diagnosed Diabetes and Obesity. Available at: http://www.cdc.gov/diabetes/statistics/. Accessed September 24, 2015
11. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
12. World Health Organization: Obesity and Overweight Fact Sheet, 2013. Available at: http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf. Accessed August 13, 2015
13. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, Bucher HC, Nordmann AJ: Bariatric surgery versus nonsurgical treatment for obesity: A systematic review and metaanalysis of randomised controlled trials. BMJ 347: f5934, 2013
14. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland MA, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Harrison B, Hazuda HP, Hill JO, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Kitabchi AE, Knowler WC, Lewis CE, Maschak-Carey BJ, Montez MG, Murillo A, Nathan DM, Patricio J, Peters A, Pi-Sunyer X, Pownall H, Reboussin D, Regensteiner JG, Rickman AD, Ryan DH, Safford M, Wadden TA, Wagenknecht LE, West DS, Williamson DF, Yanovski SZ; Look AHEAD Research Group: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369: 145-154, 2013
15. Van Gaal L, Scheen A: Weight management in type 2 diabetes: Current and emerging approaches to treatment. Diabetes Care 38: 1161-1172, 2015
16. Daubresse M, Alexander GC: The uphill battle facing antiobesity drugs. Int J Obes 39: 377-378, 2015
17. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, Wing RR, Bertoni AG; Look AHEAD Research Group: Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308: 2489-2496, 2012
18. Muller-Stich BP, Senft JD, Warschkow R, Kenngott HG, Billeter AT, Vit G, Helfert S, Diener MK, Fischer L, Buchler MW, Nawroth PP: Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: A systematic review and metaanalysis. Ann Surg 261: 421-429, 2015
19. Ikramuddin S, Billington CJ, Lee WJ, Bantle JP, Thomas AJ, Connett JE, Leslie DB, Inabnet WB 3rd, Jeffery RW, Chong K, Chuang LM, Sarr MG, Jensen MD, Vella A, Ahmed L, Belani K, Schone JL, Olofson AE, Bainbridge HA, Laqua PS, Wang Q, Korner J: Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 3: 413-422, 2015
20. Courcoulas AP, Belle SH, Neiberg RH, Pierson SK, Eagleton JK, Kalarchian MA, DeLany JP, Lang W, Jakicic JM: Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial [published online ahead of print July 1, 2015]. JAMA Surg doi: 10.1001/jamasurg.2015.1534
21. American Diabetes Association: Standards of medical care in diabetes-2013. Diabetes Care 36[Suppl 1]: S11-S66, 2013
22. Yu J, Zhou X, Li L, Li S, Tan J, Li Y, Sun X: The long-term effects of bariatric surgery for type 2 diabetes: Systematic review and metaanalysis of randomized and non-randomized evidence. Obes Surg 25: 143-158, 2015
23. Seeley RJ, Chambers AP, Sandoval DA: The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab 21: 369-378, 2015
24. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H; Swedish Obese Subjects Study Scientific Group: Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351: 2683-2693, 2004
25. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR; STAMPEDE Investigators: Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 370: 2002-2013, 2014
26. Friedman AN, Moe S, Fadel WF, Inman M, Mattar SG, Shihabi Z, Quinney SK: Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 39: 8-15, 2014
27. Navaneethan SD, Malin SK, Arrigain S, Kashyap SR, Kirwan JP, Schauer PR: Bariatric surgery, kidney function, insulin resistance, and adipokines in patients with decreased GFR: A cohort study. Am J Kidney Dis 65: 345-347, 2015
28. Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 54: 205-226, 2009
29. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA: The effectiveness and risks of bariatric surgery: An updated systematic review and meta-analysis, 2003-2012. JAMA Surg 149: 275-287, 2014
30. Courcoulas AP, Christian NJ, Belle SH, Berk PD, Flum DR, Garcia L, Horlick M, Kalarchian MA, King WC, Mitchell JE, Patterson EJ, Pender JR, Pomp A, Pories WJ, Thirlby RC, Yanovski SZ, Wolfe BM; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium: Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310: 2416-2425, 2013
31. Turgeon NA, Perez S, Mondestin M, Davis SS, Lin E, Tata S, Kirk AD, Larsen CP, Pearson TC, Sweeney JF: The impact of renal function on outcomes of bariatric surgery. J Am Soc Nephrol 23: 885-894, 2012
32. Saleh F, Kim SJ, Okrainec A, Jackson TD: Bariatric surgery in patients with reduced kidney function: An analysis of short-term outcomes. Surg Obes Relat Dis 11: 828-835, 2015
33. Cloyd JM, Ma Y, Morton JM, Kurella Tamura M, Poultsides GA, Visser BC: Does chronic kidney disease affect outcomes after major abdominal surgery? Results from the National Surgical Quality Improvement Program. J Gastrointest Surg 18: 605-612, 2014
34. Weingarten TN, Gurrieri C, McCaffrey JM, Ricter SJ, Hilgeman ML, Schroeder DR, Kendrick ML, Greene EL, Sprung J: Acute kidney injury following bariatric surgery. Obes Surg 23: 64-70, 2013
35. Lieske JC, Mehta RA, Milliner DS, Rule AD, Bergstralh EJ, Sarr MG: Kidney stones are common after bariatric surgery. Kidney Int 87: 839-845, 2015
36. Maalouf NM, Tondapu P, Guth ES, Livingston EH, Sakhaee K: Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery. J Urol 183: 1026-1030, 2010
37. Sinha MK, Collazo-Clavell ML, Rule A, Milliner DS, Nelson W, Sarr MG, Kumar R, Lieske JC: Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72: 100-107, 2007
38. Nasr SH, D’Agati VD, Said SM, Stokes MB, Largoza MV, Radhakrishnan J, Markowitz GS: Oxalate nephropathy complicating Roux-en-Y Gastric Bypass: An underrecognized cause of irreversible renal failure. Clin J Am Soc Nephrol 3: 1676-1683, 2008
39. Maciejewski ML, Arterburn DE: Cost-effectiveness of bariatric surgery. JAMA 310: 742-743, 2013
40. Nichols GA, Vupputuri S, Lau H: Medical care costs associated with progression of diabetic nephropathy. Diabetes Care 34: 2374-2378, 2011
41. Courcoulas AP, Yanovski SZ, Bonds D, Eggerman TL, Horlick M, Staten MA, Arterburn DE: Long-term outcomes of bariatric surgery: A National Institutes of Health symposium. JAMA Surg 149: 1323-1329, 2014
42. DeMaria EJ: Bariatric surgery for morbid obesity. N Engl J Med 356: 2176-2183, 2007
43. Izzedine H, Coupaye M, Reach I, Deray G: Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabet Med 22: 1761-1762, 2005
44. Agnani S, Vachharajani VT, Gupta R, Atray NK, Vachharajani TJ: Does treating obesity stabilize chronic kidney disease? BMC Nephrol 6: 7, 2005
45. Pérez G, Devaud N, Escalona A, Downey P: Resolution of early stage diabetic nephropathy in an obese diabetic patient after gastric bypass. Obes Surg 16: 1388-1391, 2006
46. Rubin J: Weight loss by bariatric surgery may permit patients with significant residual renal function to come off dialysis. Presented at the American Society of Nephrology Annual Conference, San Diego, CA, October 30-November 4, 2012
47. Alexander JW, Goodman HR, Hawver LR, Cardi MA: Improvement and stabilization of chronic kidney disease after gastric bypass. Surg Obes Relat Dis 5: 237-241, 2009
48. Agrawal V, Khan I, Rai B, Krause KR, Chengelis DL, Zalesin KC, Rocher LL, McCullough PA: The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 70: 194-202, 2008
49. Navaneethan SD, Yehnert H: Bariatric surgery and progression of chronic kidney disease. Surg Obes Relat Dis 5: 662-665, 2009
50. Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR: Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery. Obes Surg 20: 308-315, 2010
51. Saliba J, Kasim NR, Tamboli RA, Isbell JM, Marks P, Feurer ID, Ikizler A, Abumrad NN: Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics. Surgery 147: 282-287, 2010
52. Iaconelli A, Panunzi S, De Gaetano A, Manco M, Guidone C, Leccesi L, Gniuli D, Nanni G, Castagneto M, Ghirlanda G, Mingrone G: Effects of bilio-pancreatic diversion on diabetic complications: A 10-year follow-up. Diabetes Care 34: 561-567, 2011
53. Schuster DP, Teodorescu M, Mikami D, Foreman K, Rogers P, Needleman BJ: Effect of bariatric surgery on normal and abnormal renal function. Surg Obes Relat Dis 7: 459-464, 2011
54. Heneghan HM, Cetin D, Navaneethan SD, Orzech N, Brethauer SA, Schauer PR: Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis 9: 7-14, 2013
55. Stephenson DT, Jandeleit-Dahm K, Balkau B, Cohen N: Improvement in albuminuria in patients with type 2 diabetes after laparoscopic adjustable gastric banding. Diab Vasc Dis Res 10: 514-519, 2013
56. Aminian A, Daigle CR, Romero-Talamás H, Kashyap SR, Kirwan JP, Brethauer SA, Schauer PR: Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis 10: 576-582, 2014
57. QKidney: QKidney 5-Year Nephropathy Risk Calculator. Available at: http://www.qkidney.org/. Accessed August 13, 2015
58. MacLaughlin HL, Hall WL, Patel AG, Blacklock RM, Swift PA, Phanish MK, Dew T, Chowdhury P, Sanders TA, Macdougall IC: Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3-4 CKD: A randomized controlled pilot study. Am J Kidney Dis 64: 660-663, 2014
59. Miras AD, Chuah LL, Khalil N, Nicotra A, Vusirikala A, Baqai N, Graham C, Ravindra S, Lascaratos G, Oliver N, le Roux CW: Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: A case-control study. Diabetologia 58: 1443-1447, 2015